BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

13 articles for RJ Schotzinger

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and optimization of highly-selective fungal CYP51 inhibitors.EBI
Viamet Pharmaceuticals
Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors.EBI
Viamet Pharmaceuticals
Development of Highly Selective Pyrimidine-Based Aldosterone Synthase (CYP11B2) Inhibitors.EBI
Selenity Therapeutics
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.EBI
Viamet Pharmaceuticals
A novel small-molecule tumor necrosis factor a inhibitor attenuates inflammation in a hepatitis mouse model.BDB
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Phenylcyclopropylamine derivatives and their medical useBDB
Oryzon Genomics
Simple Pseudo-dipeptides with a P2' Glutamate: A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS.BDB
French Alternative Energies and Atomic Energy Commission
Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.BDB
Merck Sharp and Dohme Research Laboratories
Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.BDB
University of Nebraska
Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.BDB
Pfizer